Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dallas J Smith

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Pharmacotherapy|March 13, 2026
Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases PharmacistsCaleb E Rux, Melissa D Johnson, Victoria C Grant, et al.
Clinical Microbiology Reviews|March 5, 2026
Contribution of fungal diseases to the U.S. chronic disease burdenRia R Ghai, Kaitlin Benedict, Tom M Chiller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2023
Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care ProvidersDallas J Smith, Rebecca J Free, George R Thompson, et al.
MMWR. Morbidity and Mortality Weekly Report|February 12, 2026
Purpureocillium lilacinum Keratitis Outbreak Associated with an Ophthalmology Clinic - New York City, 2024Michelle E Chang, Elise Mantell, William G Greendyke, et al.
Frontiers in Pharmacology|July 28, 2023
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countriesDallas J Smith, Huichang Bi, Josias Hamman, et al.
Nature Communications|February 2, 2026
Integrated action for skin NTDs: Deconstructing transmission, addressing knowledge gaps, and championing one health strategiesLydia Mosi, Bishwanath Acharya, Kingsley Asiedu, et al.
Open Forum Infectious Diseases|November 29, 2024
Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024Jordan B Singleton, Dennis Wang, Souci Louis, et al.
Emerging Infectious Diseases|March 4, 2024
Potential Sexual Transmission of Antifungal-Resistant Trichophyton indotineaeStephanie Spivack, Jeremy A W Gold, Shawn R Lockhart, et al.
Journal of Fungi (Basel, Switzerland)|August 25, 2023
Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save LivesDallas J Smith, Jeremy A W Gold, Kaitlin Benedict, et al.
Emerging Infectious Diseases|September 25, 2024
Associations between Minority Health Social Vulnerability Index Scores, Rurality, and Histoplasmosis Incidence, 8 US StatesDallas J Smith, Malavika Rajeev, Kristina Boyd, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Pharmacotherapy|March 13, 2026
Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases PharmacistsCaleb E Rux, Melissa D Johnson, Victoria C Grant, et al.
Clinical Microbiology Reviews|March 5, 2026
Contribution of fungal diseases to the U.S. chronic disease burdenRia R Ghai, Kaitlin Benedict, Tom M Chiller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2023
Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care ProvidersDallas J Smith, Rebecca J Free, George R Thompson, et al.
MMWR. Morbidity and Mortality Weekly Report|February 12, 2026
Purpureocillium lilacinum Keratitis Outbreak Associated with an Ophthalmology Clinic - New York City, 2024Michelle E Chang, Elise Mantell, William G Greendyke, et al.
Frontiers in Pharmacology|July 28, 2023
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countriesDallas J Smith, Huichang Bi, Josias Hamman, et al.
Nature Communications|February 2, 2026
Integrated action for skin NTDs: Deconstructing transmission, addressing knowledge gaps, and championing one health strategiesLydia Mosi, Bishwanath Acharya, Kingsley Asiedu, et al.
Open Forum Infectious Diseases|November 29, 2024
Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024Jordan B Singleton, Dennis Wang, Souci Louis, et al.
Emerging Infectious Diseases|March 4, 2024
Potential Sexual Transmission of Antifungal-Resistant Trichophyton indotineaeStephanie Spivack, Jeremy A W Gold, Shawn R Lockhart, et al.
Journal of Fungi (Basel, Switzerland)|August 25, 2023
Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save LivesDallas J Smith, Jeremy A W Gold, Kaitlin Benedict, et al.
Emerging Infectious Diseases|September 25, 2024
Associations between Minority Health Social Vulnerability Index Scores, Rurality, and Histoplasmosis Incidence, 8 US StatesDallas J Smith, Malavika Rajeev, Kristina Boyd, et al.
Pageof 7